Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company''s products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera; and SurgiBot System, a single-port robotically enhanced laparoscopic surgical platform. Its products also comprise instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is based in Durham, North Carolina.

ASXC price history

interval date selector

agregation type selector

Date

Change

Chg%

Open

Min.

Max.

2022-09-30

0.3235

0.0000

0.00

0.3235

Trade Asensus Surgical, Inc. - ASXC stock price

The Power Of Leverage

ASXC price history

LIus Li Auto Inc	17.30+0.03%	Trade
BTBT Bit Digital, Inc.	2.0330+0.09%	Trade
BB BlackBerry Limited	3.87+0.01%	Trade
ABNB Airbnb Inc	134.01-0.02%	Trade
NU Nu Holdings Ltd.	16.97+0.01%	Trade
CRWD CrowdStrike Holdings, Inc.	451.81-0.03%	Trade
DBX Dropbox	26.67-0.04%	Trade
TIT Telecom Italia SPA	0.511-0.01%	Trade
MOS Mosaic	25.01+0.03%	Trade
BA Boeing Co	222.40+0.03%	Trade